TW

Travis T. Wager

Pfizer: 24 patents #98 of 5,153Top 2%
Overall (All Time): #170,553 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12049465 Tricyclic compounds and their use as phosphodiesterase inhibitors Thomas Allen Chappie, Nandini Chaturbhai Patel, Patrick Robert Verhoest, Christopher John Helal, Simone Sciabola +2 more 2024-07-30
11472805 Tricyclic compounds and their use as phosphodiesterase inhibitors Thomas Allen Chappie, Nandini Chaturbhai Patel, Patrick Robert Verhoest, Christopher John Helal, Simone Sciabola +2 more 2022-10-18
11390623 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Thomas Allen Chappie, Jaclyn Louise Henderson, Joseph Michael Young, Bethany Lyn Kormos, Nandini Chaturbhai Patel +4 more 2022-07-19
11312713 Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Michael Aaron Brodney, Thomas Allen Chappie, Jinshan Chen, Jotham Wadsworth Coe, Karen Coffman +14 more 2022-04-26
11161844 Cyclic substituted imidazo[4,5-c]quinoline derivatives Thomas Allen Chappie, Paul Galatsis, Michelle Renee Garnsey, Christopher John Helal, Jaclyn Louise Henderson +5 more 2021-11-02
10738063 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds Thomas Allen Chappie, Nandini Chaturbhai Patel, Patrick Robert Verhoest, Christopher John Helal, Simone Sciabola +2 more 2020-08-11
10590128 6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands Thomas Allen Chappie, Jaclyn Louise Henderson, Joseph Michael Young, Bethany Lyn Kormos, Nandini Chaturbhai Patel +4 more 2020-03-17
10323042 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds Thomas Allen Chappie, Nandini Chaturbhai Patel, Patrick Robert Verhoest, Christopher John Helal, Simone Sciabola +2 more 2019-06-18
10131669 Pyrazolopyrimidine compounds Thomas Allen Chappie, Patrick Robert Verhoest, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal +3 more 2018-11-20
10039753 Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors Karen Coffman, Paul Galatsis, Michelle Renee Garnsey, Jaclyn Louise Henderson, Bethany Lyn Kormos +5 more 2018-08-07
9695171 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors Paul Galatsis, Matthew Merrill Hayward, Bethany Lyn Kormos, Lei Zhang, Jaclyn Louise Henderson +3 more 2017-07-04
9642855 Substituted pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors Paul Galatsis, Matthew Merrill Hayward, Bethany Lyn Kormos, Lei Zhang, Antonia Friederike Stepan +3 more 2017-05-09
9156845 4-(substituted amino)-7H-pyrrolo[2,3-d] pyrimidines as LRRK2 inhibitors Paul Galatsis, Matthew Merrill Hayward, Bethany Lyn Kormos, Lei Zhang, Antonia Friederike Stepan +3 more 2015-10-13
8536164 Fused pyridine compounds as casein kinase inhibitors Todd W. Butler, Ramalakshmi Yegna Chandrasekaran, Scot Richard Mente, Chakrapani Subramanyam 2013-09-17
8518944 Compounds as casein kinase inhibitors Chakrapani Subramanyam 2013-08-27
8389743 Histamine-3 receptor antagonists Ramalakshmi Yegna Chandrasekaran, Todd W. Butler 2013-03-05
8314139 Toluene sulfonic acid salt of a therapeutic compound and pharmaceutical compositions thereof Todd W. Butler 2012-11-20
8178574 Tosylate salt of trans-N-isobutyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-yl-methyl)-phenyl] cyclobut anecarboxamide Todd W. Butler 2012-05-15
8158673 Histamine-3 receptor antagonists Ramalakshmi Yegna Chandrasekaran, Todd W. Butler 2012-04-17
7812040 Histamine-3 receptor antagonists 2010-10-12
7300944 Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors Daniel Wei-Shung Kung 2007-11-27
7300943 GSK-3 inhibitors 2007-11-27
7241798 NK1 antagonists Barbara E. Segelstein, Willard M. Welch, Jr. 2007-07-10
7115600 Histamine-3 receptor modulators Ramalakshmi Yegna Chandrasekaran 2006-10-03